Psoriasin (S100A7) associates with integrin ?6 subunit and is required for ?v?6-dependent carcinoma cell invasion
Psoriasin (S100A7) associates with integrin ?6 subunit and is required for ?v?6-dependent carcinoma cell invasion
Expression of the integrin ?v?6 is upregulated in a variety of carcinomas where it appears to be involved in malignant progression, although the biology of this integrin is not fully explored. We have generated oral carcinoma cells that express ?v?6 composed of wild-type ?v and a mutant ?6 that lacks the unique C-terminal 11 amino acids (aa). We found that these residues, although not required for ?v?6-dependent adhesion or migration, are essential for ?v?6-dependent invasive activity. We have used a proteomic approach to identify novel binding partners for the ?6 subunit cytoplasmic tail and report that psoriasin (Psor) (S100A7) bound preferentially to the recombinant ?6 cytoplasmic domain, though not in the absence of the unique C-terminal 11aa. Endogenous cellular Psor co-precipitated with endogenous ?6 and colocalised with ?v?6 at the cell membrane and intracellular vesicles. Knockdown of Psor, with small interfering RNA, had no effect on ?v?6-dependent adhesion or migration but abrogated ?v?6-mediated oral carcinoma cell invasion both in Transwell and, the more physiologically relevant, organotypic invasion assays, recapitulating the behaviour of the ?6-mutant cell line. Membrane-permeant Tat-peptides encoding the unique C-terminal residues of ?6, bound directly to recombinant Psor and inhibited cellular Psor binding to ?6; this blocked ?v?6-dependent, but not ?v?6-independent, invasion. These data identify a novel interaction between Psor and ?6 and demonstrate that it is required for ?v?6-dependent invasion by carcinoma cells. Inhibition of this interaction may represent a novel therapeutic strategy to target carcinoma invasion.
?v?6, integrins, invasion, psoriasin, cancer, oral scc
1422-1435
Morgan, M.R.
2b333082-6d38-49a4-ad86-ae3ebc8d55a5
Jazayeri, M.
487a4e9f-0710-451c-bf7a-0fb271adfb59
Ramsey, A.G.
534b3758-33c1-400c-9de7-e0192273f8c4
Thomas, G.J.
2ff54aa9-a766-416b-91ee-cf1c5be74106
Boulanger, M.J
19958ce7-3d57-41c6-aa2e-ea00488ac627
Hart, I.R.
7bfb93f0-86c5-4200-af57-fd7f251076c1
Marshall, J.F.
0f31dde6-5c31-4070-9c54-2e2f59711014
24 March 2011
Morgan, M.R.
2b333082-6d38-49a4-ad86-ae3ebc8d55a5
Jazayeri, M.
487a4e9f-0710-451c-bf7a-0fb271adfb59
Ramsey, A.G.
534b3758-33c1-400c-9de7-e0192273f8c4
Thomas, G.J.
2ff54aa9-a766-416b-91ee-cf1c5be74106
Boulanger, M.J
19958ce7-3d57-41c6-aa2e-ea00488ac627
Hart, I.R.
7bfb93f0-86c5-4200-af57-fd7f251076c1
Marshall, J.F.
0f31dde6-5c31-4070-9c54-2e2f59711014
Morgan, M.R., Jazayeri, M., Ramsey, A.G., Thomas, G.J., Boulanger, M.J, Hart, I.R. and Marshall, J.F.
(2011)
Psoriasin (S100A7) associates with integrin ?6 subunit and is required for ?v?6-dependent carcinoma cell invasion.
Oncogene, 30 (12), .
(doi:10.1038/onc.2010.535).
(PMID:21132011)
Abstract
Expression of the integrin ?v?6 is upregulated in a variety of carcinomas where it appears to be involved in malignant progression, although the biology of this integrin is not fully explored. We have generated oral carcinoma cells that express ?v?6 composed of wild-type ?v and a mutant ?6 that lacks the unique C-terminal 11 amino acids (aa). We found that these residues, although not required for ?v?6-dependent adhesion or migration, are essential for ?v?6-dependent invasive activity. We have used a proteomic approach to identify novel binding partners for the ?6 subunit cytoplasmic tail and report that psoriasin (Psor) (S100A7) bound preferentially to the recombinant ?6 cytoplasmic domain, though not in the absence of the unique C-terminal 11aa. Endogenous cellular Psor co-precipitated with endogenous ?6 and colocalised with ?v?6 at the cell membrane and intracellular vesicles. Knockdown of Psor, with small interfering RNA, had no effect on ?v?6-dependent adhesion or migration but abrogated ?v?6-mediated oral carcinoma cell invasion both in Transwell and, the more physiologically relevant, organotypic invasion assays, recapitulating the behaviour of the ?6-mutant cell line. Membrane-permeant Tat-peptides encoding the unique C-terminal residues of ?6, bound directly to recombinant Psor and inhibited cellular Psor binding to ?6; this blocked ?v?6-dependent, but not ?v?6-independent, invasion. These data identify a novel interaction between Psor and ?6 and demonstrate that it is required for ?v?6-dependent invasion by carcinoma cells. Inhibition of this interaction may represent a novel therapeutic strategy to target carcinoma invasion.
This record has no associated files available for download.
More information
Published date: 24 March 2011
Keywords:
?v?6, integrins, invasion, psoriasin, cancer, oral scc
Organisations:
Cancer Sciences
Identifiers
Local EPrints ID: 339676
URI: http://eprints.soton.ac.uk/id/eprint/339676
ISSN: 0950-9232
PURE UUID: 01a579e8-a827-4651-bf74-f345ef7b837f
Catalogue record
Date deposited: 29 May 2012 10:41
Last modified: 14 Mar 2024 11:14
Export record
Altmetrics
Contributors
Author:
M.R. Morgan
Author:
M. Jazayeri
Author:
A.G. Ramsey
Author:
M.J Boulanger
Author:
I.R. Hart
Author:
J.F. Marshall
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics